The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

被引:4
作者
Hu, Yingying [1 ,2 ]
Zhou, Fan [3 ,4 ]
Lei, Fang [2 ,5 ]
Lin, Lijin [1 ,2 ]
Huang, Xuewei [6 ]
Sun, Tao [1 ,2 ]
Liu, Weifang [1 ,2 ]
Zhang, Xingyuan [2 ,5 ]
Cai, Jingjing [2 ,6 ]
She, Zhi-Gang [1 ,2 ]
Li, Hongliang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China
[3] Yangtze Univ, Huanggang Cent Hosp, Dept Gastroenterol, Huanggang, Peoples R China
[4] Huanggang Inst Translat Med, Huanggang, Peoples R China
[5] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China
[6] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
基金
美国国家科学基金会;
关键词
metabolic dysfunction-associated fatty liver disease; thyroid function parameters; nonlinear relationship; restricted cubic spline analysis; multivariable-adjusted logistic regression models; STIMULATES LEPTIN SECRETION; FREE TRIIODOTHYRONINE; ADIPOSE-TISSUE; HORMONE; RISK; NAFLD; HYPOTHYROIDISM; PATHOGENESIS; THYROTROPIN; PREVALENCE;
D O I
10.3389/fendo.2023.1115354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease (MAFLD) remains controversial. Additionally, little is known about the relationship between thyroid function parameters and MAFLD in the Chinese population. MethodsWe conducted a retrospective cross-sectional study involving 177,540 individuals with thyroid function tests and MAFLD diagnosis from 2010-2018. The association between thyroid function parameters and MAFLD was evaluated on a continuous scale with restricted cubic spline (RCS) models and by the prior-defined centile categories with multivariable-adjusted logistic regression models. Thyroid function parameters included free triiodothyronine (FT3), free tetra-iodothyronine (FT4), and thyroid stimulating hormone (TSH). Additionally, fully adjusted RCS models stratified by sex, age, and location were studied. ResultsIn the RCS models, the risk of MAFLD increased with higher levels of FT3 when FT3 <5.58pmol/L, while the risk of MAFLD decreased with higher levels of FT3 when FT3 >= 5.58pmol/L (P nonlinearity <0.05). While RCS analysis suggested that the FT4 levels had a negative association with MAFLD (P nonlinearity <0.05), indicating an increase in FT4 levels was associated with a decreased risk of MAFLD. RCS analysis suggested an overall positive association between the concentration of TSH and MAFLD risk (P nonlinearity <0.05). The rising slope was sharper when the TSH concentration was less than 1.79uIU/mL, which indicated the association between TSH and MAFLD risk was tightly interrelated within this range. The multivariable logistic regression showed that populations in the 81st-95th centile had the highest risk of MAFLD among all centiles of FT3/TSH, with the 1st-5th centile as the reference category. ConclusionsOur study suggested nonlinear relationships between thyroid function parameters and MAFLD. Thyroid function parameters could be additional modifiable risk factors apart from the proven risk factors to steer new avenues regarding MAFLD prevention and treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [42] Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal study
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Sei, Motoko
    Kagemoto, Kaizo
    Tanaka, Hironori
    Kida, Yoshifumi
    Nakamura, Fumika
    Tomonari, Tetsu
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (04) : 754 - 761
  • [43] Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
    Fan, Jian-Gao
    Xu, Xiao-Yuan
    Yang, Rui-Xu
    Nan, Yue-Min
    Wei, Lai
    Jia, Ji-Dong
    Zhuang, Hui
    Shi, Jun-Ping
    Li, Xiao-Ying
    Sun, Chao
    Li, Jie
    Wong, Vincent Wai-Sun
    Duan, Zhong-Ping
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (11) : 955 - 974
  • [44] Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Kani, Haluk Tarik
    Demirtas, Coskun Ozer
    Keklikkiran, Caglayan
    Ergenc, Ilkay
    Mehdiyev, Shahin
    Akdeniz, Esra
    Yilmaz, Yusuf
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (08) : 661 - 666
  • [45] Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study
    van Kleef, Laurens A.
    Ayada, Ibrahim
    Alferink, Louise J. M.
    Pan, Qiuwei
    Knegt, Robert J.
    HEPATOLOGY, 2022, 75 (02) : 419 - 429
  • [46] Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
    Tanaka, Marenao
    Mori, Kazuma
    Takahashi, Satoko
    Higashiura, Yukimura
    Ohnishi, Hirofumi
    Hanawa, Nagisa
    Furuhashi, Masato
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (03) : 700 - 711
  • [47] Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population
    Lee, Guan Huei
    Phyo, Wah Wah
    Loo, Wai Mun
    Kwok, Raymond
    Ahmed, Taufique
    Shabbir, Asim
    So, Jimmy
    Koh, Calvin Jianyi
    Hartono, Juanda Leo
    Muthiah, Mark
    Lim, Kieron
    Tan, Poh Seng
    Lee, Yin Mei
    Lim, Seng Gee
    Dan, Yock Young
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (12) : 1228 - 1238
  • [48] A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
    Efrem, Ion Cristian
    Mota, Maria
    Vladu, Ionela Mihaela
    Mitrea, Adina
    Clenciu, Diana
    Timofticiuc, Diana Cristina Protasiewicz
    Diaconu, Ileana-Diana
    Turcu, Adina
    Crisan, Anda Elena
    Geormaneanu, Cristiana
    Glodeanu, Adina Dorina
    Mahler, Beatrice
    Tudor, Marinela Sinziana
    Amzolini, Anca Maria
    Micu, Simona Elena
    Abu Alhija, Anca Barau
    Mita, Adrian
    Filip, Maria Monalisa
    Fortofoiu, Maria
    DIAGNOSTICS, 2022, 12 (10)
  • [49] Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications
    Pirola, Carlos J.
    Sookoian, Silvia
    CURRENT OPINION IN LIPIDOLOGY, 2022, 33 (02) : 95 - 102
  • [50] Risk scores for metabolic dysfunction-associated fatty liver disease in pediatric obesity
    Lischka, Julia
    Lieb, Katharina
    Schanzer, Andrea
    Hojreh, Azadeh
    Ba-Ssalamah, Ahmed
    de Gier, Charlotte
    Walleczek, Nina-Katharina
    Zeyda, Maximilian
    Greber-Platzer, Susanne
    ANNALS OF NUTRITION AND METABOLISM, 2022, 78 (05) : 247 - 254